This Fund Built Million: Masimo Stock Surges After Major Deal Announcement
A patient investment fund quietly grabbed a multi-million stake in Masimo after a landmark deal. This article breaks ...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesA patient investment fund quietly grabbed a multi-million stake in Masimo after a landmark deal. This article breaks ...
Prentice Capital has exited its Compass position, reporting a zero stake after the latest quarter. This move highligh...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
Last year, a notable fintech stock faced a sharp decline. A major fund then exited a $4 million stake, signaling a sh...
A niche ETF that targets closed-end funds is delivering roughly 15% total return over the past year, while its holdin...
Choosing the right pharmaceutical ETF can shape your portfolio’s risk and income. This guide pits IHE against PJP, br...
A high-profile fund manager dumped a huge chunk of AMD stock in one day. The move sparked questions about portfolio s...
Two leading short-term municipal bond ETFs square off for investors seeking tax-exempt income. This guide breaks down...
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
In a fluctuating rate environment, retirees eyeing quarterly income are increasingly turning to the Vanguard Real Est...
When public moments collide with private finances, everyone feels the ripple effects. This piece explores how leaders...
A surprise move puts a legendary director in the spotlight as a leading actor. This Tangled Up in Blue project offers...